Remicade Biosimilars Market Led By Increasing Prevalence Of Chronic Inflammatory Diseases Is Driven By Cost-Effectiveness
by Remicade, also known as infliximab, is a monoclonal antibody primarily used for the treatment of various chronic inflammatory diseases such as rheumatoid arthritis, Crohn’s disease, …